[MOL] Somatostatin Receptor ;etc/ for Occullt Carcinoid Tumor [01203] Medicine On Line

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[MOL] Somatostatin Receptor ;etc/ for Occullt Carcinoid Tumor

Somatostatin Receptor Scintigraphy and Endoscopic Ultrasonography for Occult Carcinoid Tumor  

We read with interest the report by Rubio et al1 on "Carcinoid Tumor Metastatic to the Breast" in the October 1998 ARCHIVES. We agree that the presentation is consistent with carcinoid tumor metastatic to the breast; however, consideration should be given to the addition of serum chromogranin A, the somatostatin receptor for scintigraphy, and endoscopic ultrasonography to elucidate the occult primary carcinoid tumor. Chromogranin A is a valuable serum marker for neuroendocrine tumors, with the highest values found in patients with metastatic carcinoids of unknown primary sites. A correlation has been demonstrated between serum chromogranin A levels and somatostatin receptor positivity for midgut carcinoids.2 Evaluation for occult foregut carcinoid tumor should include endoscopic ultrasonography, which has a sensitivity of approximately 90% for tumors smaller than 2 cm.3 Scintigraphy combines the advantage of whole-body imaging with sensitivity of 75% to 100% and specificity of 90% to 100% to detect the unknown primary tumor and other sites of metastasis.4 Following external scintigraphy, gamma-detection probes can be employed intraoperatively to assist in the detection of nonpalpable (<5 mm), surgically occult lesions. 5

Finally, positive somatostatin uptake on scintigraphy predicts the efficacy of future somatostatin analog therapy, a possible conduit for radiation treatment and posttreatment follow-up.6

Carmine Volpe, MD
Ralph J. Doerr, MD
Buffalo, NY


1. Rubio IT, Korourian S, Brown H, Cowan C, Klimberg VS. Carcinoid tumor metastatic to the breast. Arch Surg. 1998;133:1117-1119. MEDLINE

2. Wiedemann B, Bader M, Scherubl H, et al. Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy. Semin Oncol. 1994;21(suppl 13):29-32. MEDLINE

3. Zimmer T, Ziegler K, Bader M, et al. Localisation of neuroendocrine tumors of the upper gastrointestinal tract. Gut. 1994;35:471-475. MEDLINE

4. Hoegertle S, Nitzsche EU, Stumpf A, et al. Incidental appendix carcinoid: value of somatostatin receptor imaging. Clin Nucl Med. 1997;22:467-469. MEDLINE

5. Ohrvall U, Westlin JE, Nilsson S, et al. Intraoperative gamma detection reveals abdominal endocrine tumors more efficiently than somatostatin receptor scintigraphy. Cancer. 1997;80(suppl 12):290-294.

6. Nilsson O, Kolby L, Wangberg B, et al. Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours. Br J Cancer. 1998;77:632-637. MEDLINE

Warmly, lillian
We invite you to take a look at our Album.                                               
  ( Very informational, good tips, Molers pictures, art work and much more....